These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 15458457)
1. Early prediction of IgA nephropathy progression: proteinuria and AOPP are strong prognostic markers. Descamps-Latscha B; Witko-Sarsat V; Nguyen-Khoa T; Nguyen AT; Gausson V; Mothu N; Cardoso C; Noël LH; Guérin AP; London GM; Jungers P Kidney Int; 2004 Oct; 66(4):1606-12. PubMed ID: 15458457 [TBL] [Abstract][Full Text] [Related]
2. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586 [TBL] [Abstract][Full Text] [Related]
3. Role of uteroglobin G38A polymorphism in the progression of IgA nephropathy in Japanese patients. Narita I; Saito N; Goto S; Jin S; Omori K; Sakatsume M; Gejyo F Kidney Int; 2002 May; 61(5):1853-8. PubMed ID: 11967037 [TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy. Peters HP; van den Brand JA; Wetzels JF Neth J Med; 2009 Feb; 67(2):54-61. PubMed ID: 19299847 [TBL] [Abstract][Full Text] [Related]
5. Systemic redox biomarkers and their relationship to prognostic risk markers in autosomal dominant polycystic kidney disease and IgA nephropathy. Tariq A; Mansoor MA; Marti HP; Jonsson G; Slettan A; Weeraman P; Apeland T Clin Biochem; 2018 Jun; 56():33-40. PubMed ID: 29655960 [TBL] [Abstract][Full Text] [Related]
6. The retrospective analysis of 343 Czech patients with IgA nephropathy--one centre experience. Maixnerova D; Bauerova L; Skibova J; Rysava R; Reiterova J; Merta M; Honsova E; Tesar V Nephrol Dial Transplant; 2012 Apr; 27(4):1492-8. PubMed ID: 21891776 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria. Chen D; Liu J; Duan S; Chen P; Tang L; Zhang L; Feng Z; Cai G; Wu J; Chen X Kidney Blood Press Res; 2018; 43(2):318-328. PubMed ID: 29529608 [TBL] [Abstract][Full Text] [Related]
8. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy. Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844 [TBL] [Abstract][Full Text] [Related]
9. Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients. Zittema D; van den Brand JA; Bakker SJ; Wetzels JF; Gansevoort RT Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i146-i153. PubMed ID: 28057871 [TBL] [Abstract][Full Text] [Related]
10. Factors predicting progression of IgA nephropathies. Coppo R; D'Amico G J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675 [TBL] [Abstract][Full Text] [Related]
11. Proteinuria in the prognosis of IgA nephropathy. Aucella F; Netti GS; Piemontese M; Cincione IR; Infante B; Gesualdo L Minerva Urol Nefrol; 2009 Sep; 61(3):235-48. PubMed ID: 19773725 [TBL] [Abstract][Full Text] [Related]
12. Long-term prognosis of clinically early IgA nephropathy is not always favorable. Lee H; Hwang JH; Paik JH; Ryu HJ; Kim DK; Chin HJ; Oh YK; Joo KW; Lim CS; Kim YS; Lee JP BMC Nephrol; 2014 Jun; 15():94. PubMed ID: 24946688 [TBL] [Abstract][Full Text] [Related]
13. IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. Coppo R; Peruzzi L; Amore A; Piccoli A; Cochat P; Stone R; Kirschstein M; Linné T J Am Soc Nephrol; 2007 Jun; 18(6):1880-8. PubMed ID: 17513327 [TBL] [Abstract][Full Text] [Related]
14. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China. Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258 [TBL] [Abstract][Full Text] [Related]
15. Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy. Thompson A; Carroll K; A Inker L; Floege J; Perkovic V; Boyer-Suavet S; W Major R; I Schimpf J; Barratt J; Cattran DC; S Gillespie B; Kausz A; W Mercer A; Reich HN; H Rovin B; West M; Nachman PH Clin J Am Soc Nephrol; 2019 Mar; 14(3):469-481. PubMed ID: 30635299 [TBL] [Abstract][Full Text] [Related]
16. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities. Fialová L; Kalousová M; Soukupová J; Sulková S; Merta M; Jelínková E; Horejsí M; Srámek P; Malbohan I; Mikulíková L; Tesar V; Zima T Kidney Blood Press Res; 2004; 27(2):88-95. PubMed ID: 14739577 [TBL] [Abstract][Full Text] [Related]
17. IgA nephropathy: 23 years of follow-up. Milovanceva-Popovska M; Grcevska L; Dzikova S; Ristovska V; Nikolov V; Polenakovic M Prilozi; 2006 Dec; 27(2):13-27. PubMed ID: 17211288 [TBL] [Abstract][Full Text] [Related]
18. Presentation, prognosis and outcome of IgA nephropathy in Indian adults. Chacko B; John GT; Neelakantan N; Korula A; Balakrishnan N; Kirubakaran MG; Jacob CK Nephrology (Carlton); 2005 Oct; 10(5):496-503. PubMed ID: 16221102 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the Haas and the Oxford classifications for prediction of renal outcome in patients with IgA nephropathy. Park KS; Han SH; Kie JH; Nam KH; Lee MJ; Lim BJ; Kwon YE; Kim YL; An SY; Kim CH; Doh FM; Koo HM; Oh HJ; Kang SW; Choi KH; Jeong HJ; Yoo TH Hum Pathol; 2014 Feb; 45(2):236-43. PubMed ID: 24439222 [TBL] [Abstract][Full Text] [Related]
20. Primary glomerulonephritis: an update on renal survival and determinants of progression. Moranne O; Watier L; Rossert J; Stengel B; QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]